Search results for "METHYLATION"

showing 10 items of 607 documents

TMPRSS4: a novel tumor prognostic indicator for the stratification of stage IA tumors and a liquid biopsy biomarker for NSCLC patients

2019

Relapse rates in surgically resected non-small-cell lung cancer (NSCLC) patients are between 30% and 45% within five years of diagnosis, which shows the clinical need to identify those patients at high risk of recurrence. The eighth TNM staging system recently refined the classification of NSCLC patients and their associated prognosis, but molecular biomarkers could improve the heterogeneous outcomes found within each stage. Here, using two independent cohorts (MDA and CIMA-CUN) and the eighth TNM classification, we show that TMPRSS4 protein expression is an independent prognostic factor in NSCLC, particularly for patients at stage I: relapse-free survival (RFS) HR, 2.42 (95% CI, 1.47&ndash

OncologyTMPRSS4medicine.medical_specialtyDNA methylation NSCLC TMPRSS4 liquid biopsy prognosisTNM staging systemNSCLCArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicineStage (cooking)Liquid biopsyLung cancer030304 developmental biology0303 health sciencesDNA methylationliquid biopsymedicine.diagnostic_testLiquid biopsybusiness.industryGeneral MedicineMethylationmedicine.diseasePrognosisBronchoalveolar lavage030220 oncology & carcinogenesisDNA methylationBiomarker (medicine)prognosisbusiness
researchProduct

Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (G…

2006

Background Methylation of the p16 promoter is one of the most frequent mechanisms of gene inactivation; its incidence is extremely variable according to the type of tumor involved. Our purpose was to analyze the hypermethylation of the p16 promoter in laryngeal squamous cell carcinomas (LSCC), salivary gland (SG) tumors and in colorectal cancer (CRC), to detect any possible association with the clinicopathological features and to determine the prognostic significance of the p16 gene in the tumors analyzed. Patients and methods The hypermethylation of the p16 promoter was prospectively analyzed, by MSP, in a consecutive series of 64 locally advanced LSCC patients, in a consecutive series of …

Oncologymedicine.medical_specialtyColorectal cancerInternal medicinemedicineHumansPromoter Regions GeneticProspective cohort studyNeoplasm StagingUnivariate analysisbusiness.industryGenes p16Incidence (epidemiology)CancerHematologyMethylationDNA Methylationmedicine.diseaseOncologyHead and Neck NeoplasmsSalivary gland cancerDNA methylationCarcinoma Squamous CellColorectal NeoplasmsbusinessP16INK4A head and neck carcinoma
researchProduct

Two independent epigenetic biomarkers predict survival in neuroblastoma.

2015

Background Neuroblastoma (NB) is the most common extracranial pediatric solid tumor with a highly variable clinical course, ranging from spontaneous regression to life-threatening disease. Survival rates for high-risk NB patients remain disappointingly low despite multimodal treatment. Thus, there is an urgent clinical need for additional biomarkers to improve risk stratification, treatment management, and survival rates in children with aggressive NB. Results Using gene promoter methylation analysis in 48 neuroblastoma tumors with microarray technology, we found a strong association between survival and gene promoter hypermethylation (P = 0.036). Hypermethylation of 70 genes significantly …

Oncologymedicine.medical_specialtyCàncer en els infantsBioinformaticsCancer in childrenEpigenetic biomarkersNeuroblastomaNeuroblastomaInternal medicineGeneticsMedicineGene silencingEpigeneticsMolecular BiologyGenetics (clinical)business.industryRetinoblastomaResearchBiochemical markersPromoterMethylationmedicine.diseasePromoter methylationDNA methylationMarcadors bioquímicsGene chip analysisbusinessDevelopmental Biology
researchProduct

DNA methylation of the CYP1A1 and GSTP1 genes and incidence of major cancers (lung, breast and colon) in the PREDIMED-Valencia study

2017

Oncologymedicine.medical_specialtyLungbusiness.industryIncidence (epidemiology)HematologyMethylationPredimedGSTP1medicine.anatomical_structureOncologyInternal medicineMedicinebusinessGeneAnnals of Oncology
researchProduct

Global and sex-specific epigenome-wide association studies for the identification of the main methylated loci related to smoking in a mediterranean p…

2019

Abstract Background Tobacco use has been reported to be the main cause of 90% of male and 80% of female lung cancers, as well as a relevant risk factor for other cancers such as oropharynx, larynx, esophagus, stomach, liver, pancreas, kidney, bladder, and colorectum. Smoking directly affects DNA methylation and although several genes have been reported to be differentially methylated in smokers, gender differences and population-specific differences remain to be further investigated. Our aim was to undertake global and sex-specific genome-wide epigenomic studies (EWAS) in a Mediterranean population to identify the main smoking DNA-methylated genes. Methods We analyzed 88 participants in the…

Oncologymedicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationAryl hydrocarbon receptor repressorHematologyMethylationmedicine.diseaseF2RL3OncologyCpG siteInternal medicineDNA methylationmedicineLung cancereducationbusinessEpigenomicsAnnals of Oncology
researchProduct

Clinical Validation of 13-gene DNA Methylation Analysis from Oral Brushing: A Non Invasive Sampling Procedure for Early Detection of Oral Squamous Ce…

2019

In a recent study our research group described a non-invasive sampling procedure based on [...]

Oncologymedicine.medical_specialtyoral brushing;oral squamous cell carcinoma; quantitative DNA methylation analysisbusiness.industryEarly detectionSampling (statistics)oral brushingoral squamous cell carcinomaInternal medicineDNA methylationMedicinequantitative DNA methylation analysisBasal cellGene DNA Methylation Analysis Oral Brushing Non Invasive Sampling Early Detection Oral Squamous Cell CarcinomabusinessNon invasive samplingGeneThe XV National and III International Congress of the Italian Society of Oral Pathology and Medicine
researchProduct

2015

Myoglobin (MB) is not only strongly expressed in myocytes, but also at much lower levels in different cancer entities. 40% of breast tumors are MB-positive, with the globin being co-expressed with markers of tumor hypoxia in a proportion of cases. In breast cancer, MB expression is associated with a positive hormone receptor status and patient prognosis. In prostate cancer, another hormone-dependent cancer type, 53% of tumors were recently shown to express MB. Especially in more aggressive prostate cancer specimen MB expression also correlates with increased patient survival rates. Both findings might be due to tumor-suppressing properties of MB in cancer cells. In contrast to muscle, MB tr…

PCA3Regulation of gene expressionProstate cancerMultidisciplinaryBreast cancerLNCaPCancer cellDNA methylationmedicineChromoplexyBiologymedicine.diseaseMolecular biologyPLOS ONE
researchProduct

PTHrP isoform expression in adipo- and osteo-differentiating human mesenchymal stem cells

2011

PTHrPSettore BIO/06 - Anatomia Comparata E Citologiamesenchymal stem cells gene expression promoter methylation
researchProduct

Epigenetics in Brain Development and Disease

2017

Parkinson's diseasemedicine.anatomical_structureBrain developmentAngelman syndromeDNA methylationCentral nervous systemmedicineDiseaseEpigeneticsBiologymedicine.diseaseNeuroscience
researchProduct

Impact of medical imaging on the epigenome – low-dose exposure in the course of computed tomography does not induce detectable changes of DNA-methyla…

2021

Computed tomography (CT) is a main contributor to artificial low-dose exposure. Understanding the biological effects induced by CT exposure and their dependency on the characteristics of photon spectra is essential for knowledge-driven risk assessment. In a previous gene expression study, we have identified upregulation of AEN, BAX, DDB2, EDA2R and FDXR after ex vivo exposure with single-energy CT and dual-energy CT (DECT). In this study, we focused on CT-induced changes of DNA methylation. This epigenetic modification of DNA is a central regulator of gene expression and instrumental in preserving genome integrity. Previous studies reported focal hypermethylation and global hypomethylation …

Pathologymedicine.medical_specialtyBlood CellsRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryLow doseComputed tomographyEpigenomeDNA MethylationPeripheral bloodEpigenomeDNA methylationMedical imagingHumansMedicineRadiology Nuclear Medicine and imagingTomography X-Ray ComputedbusinessEpigenomicsInternational Journal of Radiation Biology
researchProduct